Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Apellis Presents Positive First Data on APL-2 in C3 Glomerulopathy at ASN Kidney Week
Nia JulianNovember 8, 2019
Facebook0 Twitter Pinterest0 0 Likes
Previous

Bellicum Pharmaceuticals Presents Encouraging Preclinical Data for GoCAR-NK Cell Program at Society for Immunotherapy of Cancer Annual Meeting

Nia JulianNovember 8, 2019
Next

Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders

Nia JulianOctober 23, 2019

© 2020 Solasta Ventures. All Rights Reserved.